文献速递眼底病与葡萄膜炎青光眼白内障与屈光手术

钕钇铝石榴石后囊膜切开术后视网膜脱离、黄斑水肿和高眼压的发生率:一项基于人群的全国性研究——法国YAG 2研究

Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study-The French YAG 2 Study.
PubMed 文献 · Ophthalmology · 2022-12-26

基于法国全国代表性样本数据库的观察性队列研究,纳入2014至2017年间接受钕钇铝石榴石后囊膜切开术且术前一年无眼病史的成人患者6210例(7958次手术),随访12个月。3个月和12个月总体不良事件率分别为8.6%和13.3%,高眼压和黄斑水肿最常见,视网膜脱离全程≤0.5%。白内障术后1年内行后囊膜切开术者不良事件风险更高(HR 1.314),糖尿病患者高眼压和黄斑水肿风险更高(HR 1.233和1.810)。

要点

  • 3个月和12个月总体不良事件率分别为8.6%和13.3%,68.4%的不良事件发生在术后3个月内。
  • 高眼压和黄斑水肿3个月发生率约为5%,视网膜脱离全程≤0.5%。
  • 白内障术后1年内行后囊膜切开术者不良事件风险较高(HR 1.314),糖尿病患者高眼压和黄斑水肿风险较高。

核心结论

  • 高眼压和黄斑水肿是钕钇铝石榴石后囊膜切开术后最常见的不良事件,主要见于术后3个月内,提示需在此期间密切随访或延迟后囊膜切开术;糖尿病和白内障术后早期行后囊膜切开术是主要驱动因素。

研究设计与样本

  • 观察性队列研究,使用法国全国代表性理赔数据库,纳入2014至2017年间接受钕钇铝石榴石后囊膜切开术且术前一年无眼病史的成人患者6210例(7958次手术),术后随访12个月。

主要发现

  • 3个月和12个月总体不良事件率(≥1种目标不良事件)分别为8.6%和13.3%。
  • 在发生≥1种目标不良事件的患者中,68.4%的不良事件发生在术后3个月内。
  • 高眼压和黄斑水肿的3个月发生率约为5%,视网膜脱离在随访期间≤0.5%。
  • 白内障术后1年内行后囊膜切开术者不良事件风险高于较晚手术者(HR 1.314 [1.034-1.669],P=0.0256),尤其是黄斑水肿(HR 1.500 [1.087-2.070],P=0.0137)。
  • 糖尿病患者高眼压风险(HR 1.233 [1.005-1.513],P=0.0448)和黄斑水肿风险(HR 1.810 [1.446-2.266],P<0.0001)高于非糖尿病患者;白内障术后1至2年行后囊膜切开术者高眼压风险高于较晚手术者(HR 1.429 [1.185-1.723],P=0.0002)。

临床怎么用

  • 作者指出,高眼压和黄斑水肿主要见于术后3个月内,提示需在此期间密切随访或延迟后囊膜切开术。
  • 作者指出,糖尿病和白内障术后早期行后囊膜切开术是主要驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To estimate the incidence and assess the risk factors associated with 3 adverse events (AEs) after neodymium:yttrium-aluminum-garnet posterior capsulotomy (Nd:YAG-caps): ocular hypertension (OHT), macular edema (ME), and retinal detachment (RD). DESIGN: Observational cohort study using a nationwide claims database. PARTICIPANTS: Adults who underwent Nd:YAG-caps between 2014 and 2017, with no ocular disease history in the year before. METHODS: Patients who underwent Nd:YAG-caps were identified using data from the French national representative sample and followed up for 12 months postprocedure. The time to AE was assessed using the Kaplan-Meier method. Factors associated with AE were assessed using Cox models. MAIN OUTCOME MEASURES: Neodymium:YAG-caps epidemiology, patients' characteristics, proportion of patients with AE, and hazard ratios (HRs) associated with variables identified as factors associated with AEs. RESULTS: During the study period, 6210 patients received Nd:YAG-caps (7958 procedures). The mean age (± standard deviation) at Nd:YAG-caps was 75.0 (± 10.3) years. The 3-month and 12-month overall AE rates (≥ 1 AE of interest) were 8.6% and 13.3%, respectively. Among patients with ≥ 1 AE of interest, 68.4% of AEs occurred within 3 months post-Nd:YAG-caps. Three-month rates were ≈5% for OHT and ME. Retinal detachment remained ≤ 0.5% over follow-up. Cox models showed that patients with Nd:YAG-caps performed within 1 year after cataract surgery had a higher risk of AEs than those with later Nd:YAG-caps (hazard ratio [HR], 1.314 [1.034-1.669], P = 0.0256), notably ME (HR, 1.500 [1.087-2.070], P = 0.0137). Diabetic patients were more at risk of OHT (HR, 1.233 [1.005-1.513], P = 0.0448) and ME (HR, 1.810 [1.446-2.266], P < 0.0001) than nondiabetic patients. Patients with Nd:YAG-caps performed between 1 and 2 years after cataract surgery were more at risk of OHT than patients with later Nd:YAG-caps (HR, 1.429 [1.185-1.723], P = 0.0002). CONCLUSIONS: According to a national claims database, OHT and ME were the most frequent AEs of interest post-Nd:YAG-caps, mainly observed within 3 months postprocedure, highlighting the need for a close follow-up during this period or a delayed capsulotomy. Diabetes and an early Nd:YAG-caps after cataract surgery were among the main drivers for AE occurrence. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Dot C, Schweitzer C, Labbé A, et al. Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study-The French YAG 2 Study. Ophthalmology. 2022. PMID: 36581227. doi:10.1016/j.ophtha.2022.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。